Clinical Trials
4 trialsNCT04638036 2024-04-16
TRACT-II
University Medical Center Groningen
Phase 1 Completed
NCT02910843 2023-01-10
RECAP
Swiss Cancer Institute
Phase 1 Terminated
NCT00543842 2015-02-26
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00215956 2013-12-23
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed